dc.date.accessioned2022-01-04T20:29:55Z
dc.date.available2022-01-04T20:29:55Z
dc.date.created2022-01-04T20:29:55Z
dc.date.issued2013
dc.identifierhttps://hdl.handle.net/20.500.12866/10396
dc.identifierhttps://doi.org/10.1186/1471-2334-13-426
dc.description.abstractBackground: Syphilis is an important sexually transmitted infection (STI) with serious public health consequences. Among men who have sex with men (MSM) in Lima, the prevalence and incidence are extraordinarily high. Current syndromic approaches, however, fail to identify asymptomatic cases, and in settings where large proportions of individuals test positive again after treatment, it is frequently difficult to distinguish treatment failure from re-infection. Thus, new approaches are needed to improve treatment strategies and public health control efforts. Methods/Design: Study participants will undergo baseline testing for syphilis infection along with a behavioral survey covering demographics, sexual behavior, drug and alcohol abuse and health-care seeking behavior. The cohort will be followed for 18 months at three-month intervals. Blood and earlobe scrapings will also be collected for T. pallidum DNA testing, to create molecular markers for subtyping. We will also perform cytokine testing on collected samples in order to create host immunologic profiles associated with recurrence, re-infection, treatment failure and success. Discussion: Advances in social epidemiology, molecular typing and characterization of host immune responses will offer promise in developing new understandings of syphilis management. We will share our findings with the Peruvian Ministry of Health and other public health organizations, to identify new approaches of case detection and successful treatment.
dc.languageeng
dc.publisherBioMed Central
dc.relationBMC Infectious Diseases
dc.relation1471-2334
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHIV
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectsingle drug dose
dc.subjectdisease surveillance
dc.subjectdisease association
dc.subjectsexual behavior
dc.subjectHomosexuality, Male
dc.subjectdemography
dc.subjectcohort analysis
dc.subjectCohort Studies
dc.subjectarticle
dc.subjectdoxycycline
dc.subjectsyphilis
dc.subjectepidemic
dc.subjectalcohol abuse
dc.subjectgamma interferon
dc.subjectinterleukin 10
dc.subjecttumor necrosis factor alpha
dc.subjecttreatment duration
dc.subjecttreatment planning
dc.subjectimmune response
dc.subjectMolecular epidemiology
dc.subjectdose response
dc.subjectmen who have sex with men
dc.subjecthelp seeking behavior
dc.subjectantibiotic resistance
dc.subjectcontrol strategy
dc.subjectdrug abuse
dc.subjectTreponema pallidum
dc.subjectmolecular typing
dc.subjectpenicillin G
dc.subjectCytokine
dc.subjectEpidemics
dc.subjecthost resistance
dc.subjectinterleukin 2
dc.subjectMacrolide resistance
dc.subjectMen who have sex with men (MSM)
dc.subjectneurosyphilis
dc.subjectprimary infection
dc.subjectprobenecid
dc.subjectprocaine penicillin
dc.subjectreinfection
dc.subjectsecondary syphilis
dc.subjectT. pallidum
dc.titleCharacterizing the syphilis epidemic among men who have sex with men in Lima, Peru to identify new treatment and control strategies
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución